Quantbot Technologies’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$453K Buy
+122,395
New +$644K 0.02% 1043
2025
Q1
– Sell
-68,927
Closed -$853K – 1934
2024
Q4
$853K Buy
+68,927
New +$920K 0.03% 685
2021
Q1
– Sell
-4,575
Closed -$36K – 1806
2020
Q4
$36K Buy
4,575
+2,895
+172% +$24.3K ﹤0.01% 921
2020
Q3
$14K Buy
1,680
+1,380
+460% +$15.1K ﹤0.01% 1063
2020
Q2
$3K Buy
+300
New +$2.82K ﹤0.01% 1047
2020
Q1
– Sell
-2,181
Closed -$17K – 1450
2019
Q4
$17K Sell
2,181
-6,646
-75% -$163K ﹤0.01% 1066
2019
Q3
$181K Buy
+8,827
New +$202K 0.02% 712
2018
Q4
– Sell
-1,416
Closed -$70K – 1469
2018
Q3
$70K Buy
+1,416
New +$63.9K ﹤0.01% 972
2018
Q2
– Sell
-2,193
Closed -$87K – 1537
2018
Q1
$87K Buy
+2,193
New +$92.2K 0.01% 886

Other funds holding WVE

Quantbot Technologies's WVE Position: Q3 2026 in Review

Quantbot Technologies opened a new position in Wave Life Sciences (WVE) in Q3 2026: 122,395 shares worth $453K. The stake represents 0.02% of the portfolio and ranks #1043 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in WVE as recently as Q4 2024.

Quantbot Technologies first reported a position in WVE in Q1 2018 and has held it in 9 quarters since. The position peaked at $853K in Q4 2024. 211 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • Quantbot Technologies held 122,395 shares of Wave Life Sciences worth $453K as of Q3 2026.
  • Wave Life Sciences was a new Quantbot Technologies position in Q3 2026.
  • Wave Life Sciences made up 0.02% of Quantbot Technologies's portfolio in Q3 2026, its #1043 holding.
  • Quantbot Technologies first reported a position in Wave Life Sciences in Q1 2018 and has held it in 9 quarters since.
  • Quantbot Technologies's Wave Life Sciences position peaked at $853K in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on Quantbot Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.